BridgeBio Pharma (BBIO) Business News Sept. 02, 2025, 11:30 UTC BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism Full text
There are no comments here yet...